Balancing the costs with the benefits
Weight loss can mean better health and lower costs for plan sponsors and members alike. Investing in these expensive, but effective drugs is a balancing act – especially when more than half of the U.S. adult population is eligible for them. Get insights on how to manage costs for the most talked-about drugs in pharmacy.
Weighty issue: How to contain anti-obesity drug costs
New anti-obesity medications are effective but expensive and more than half of U.S. adults are eligible for them. Members who reach a healthier weight are less likely to have other health complications, so their use is beneficial in the long run. But what about right now?
Plan sponsors need a game plan to balance the need for these drugs and contain the costs in their benefit plans.
How to manage blockbuster anti-obesity drugs
GLP-1 agonists: A new class of weight loss medications
Specialty and Weight Loss Webinar
Pharmacy Insights Podcast
2024: A new year promises a host of new drugs
